Hemerion appoints Dr Marie-Edith Bonneterre as Chief Medical Officer
Dr Marie-Edith Bonneterre has been appointed Chief Medical Officer (CMO) at Hemerion on September 19, 2023, to steer the medical and clinical strategy of our innovative therapeutic solutions. A specialist in cancer treatment Trained as a medical oncologist, Marie-Edith Bonneterre quickly acquired solid experience in innovative cancer treatments, with her leadership of clinical trials at …